题名 | A Zebrafish Thrombosis Model for Assessing Antithrombotic Drugs |
作者 | |
发表日期 | 2016-08 |
发表期刊 | ZEBRAFISH 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
其他关键词 | FUFANG XUESHUANTONG CAPSULE ; HEMOSTASIS ; PREVENTION ; RATS ; PHOSPHATIDYLSERINE ; EXTERNALIZATION ; IDENTIFICATION ; OCCLUSION ; TOXICITY ; DISEASE |
摘要 | Thrombosis is a leading cause of death and the development of effective and safe therapeutic agents for thrombotic diseases has been proven challenging. In this study, taking advantage of the transparency of larval zebrafish, we developed a larval zebrafish thrombosis model for drug screening and efficacy assessment. Zebrafish at 2 dpf (days post fertilization) were treated with phenylhydrazine (PHZ) and a testing drug for 24 h. Tested drugs were administered into the zebrafish either by direct soaking or circulation microinjection. Antithrombotic efficacy was quantitatively evaluated based on our previously patented technology characterized as an image analysis of the heart red blood cells stained with O-dianisidine staining. Zebrafish at 2 dpf treated with PHZ at a concentration of 1.5 mu M for a time period of 24 h were determined as the optimum conditions for the zebrafish thrombosis model development. Induced thrombosis in zebrafish was visually confirmed under a dissecting stereomicroscope and quantified by the image assay. All 6 human antithrombotic drugs (aspirin, clopidogrel, diltiazem hydrochloride injection, xuanshuantong injection, salvianolate injection, and astragalus injection) showed significant preventive and therapeutic effects on zebrafish thrombosis (p < 0.05, p < 0.01, & p < 0.001) in this zebrafish thrombosis model. The larval zebrafish thrombosis model developed and validated in this study could be used for in vivo thrombosis studies and for rapid screening and efficacy assessment of antithrombotic drugs. |
资助项目 | Zhejiang Provincial Key Science & Technology Project [2014C03009]; National Key Science & Technology Project grant of the 12th 5-year program of China [2011ZX09301-003] |
出版者 | MARY ANN LIEBERT, INC |
出版地 | NEW ROCHELLE |
ISSN | 1545-8547 |
EISSN | 1557-8542 |
卷号 | 13期号:4页码:335-344 |
DOI | 10.1089/zeb.2016.1263 |
页数 | 10 |
WOS类目 | Developmental Biology ; Zoology |
WOS研究方向 | Developmental Biology ; Zoology |
WOS记录号 | WOS:000378330600014 |
收录类别 | SCIE ; SCOPUS ; PUBMED |
URL | 查看原文 |
PubMed ID | 27333081 |
SCOPUSEID | 2-s2.0-84975840791 |
通讯作者地址 | [Li, Chun-Qi]Hunter Biotechnology,Inc.,No. 88 Jiangling Road,Hangzhou City,310051,China |
Scopus学科分类 | Animal Science and Zoology;Developmental Biology |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/7212 |
专题 | 检验医学院(生命科学学院、生物学实验教学中心)_模式生物技术与应用重点实验室 |
通讯作者 | Li, Chun-Qi |
作者单位 | 1.Zhejiang Provincial Key Lab for Technology and Application of Model Organisms,Wenzhou Medical University,Wenzhou,China; 2.Hunter Biotechnology,Inc.,No. 88 Jiangling Road,Hangzhou City,310051,China; 3.Innovation Team of Drug Safety Evaluation,Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals,Hangzhou,China; 4.Center of Safety Evaluation,Zhejiang Academy of Medical Sciences,Hangzhou,China |
第一作者单位 | 温州医科大学 |
第一作者的第一单位 | 温州医科大学 |
推荐引用方式 GB/T 7714 | Zhu, Xiao-Yu,Liu, Hong-Cui,Guo, Sheng-Ya,et al. A Zebrafish Thrombosis Model for Assessing Antithrombotic Drugs[J]. ZEBRAFISH,2016,13(4):335-344. |
APA | Zhu, Xiao-Yu., Liu, Hong-Cui., Guo, Sheng-Ya., Xia, Bo., Song, Ru-Shun., ... & Li, Chun-Qi. (2016). A Zebrafish Thrombosis Model for Assessing Antithrombotic Drugs. ZEBRAFISH, 13(4), 335-344. |
MLA | Zhu, Xiao-Yu,et al."A Zebrafish Thrombosis Model for Assessing Antithrombotic Drugs".ZEBRAFISH 13.4(2016):335-344. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论